The injection system aims to treat vertebral fractures where reducing and stabilizing the fracture is the priority. VEXIM acquired an exclusive worldwide license for Masterflow in January 2013. The company plans to begin marketing the system in the coming weeks and also plans to launch it in Europe during the first half of 2015.
More articles on devices:
The future of big orthopedic device companies: Boom or bust?
Stock report: 6 spine, orthopedic device company updates
MiMedx increases 2015 revenue projections by at least 50% — 5 key updates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
